Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

This randomized trial of RSV F protein nanoparticle vaccination during pregnancy did not show efficacy (according to the prespecified success criterion) against RSV-associated, medically significant lower respiratory tract infection but suggested possible benefits with respect to other RSV-related o...

Full description

Saved in:
Bibliographic Details
Published in:The New England journal of medicine Vol. 383; no. 5; pp. 426 - 439
Main Authors: Madhi, Shabir A, Polack, Fernando P, Piedra, Pedro A, Munoz, Flor M, Trenholme, Adrian A, Simões, Eric A.F, Swamy, Geeta K, Agrawal, Sapeckshita, Ahmed, Khatija, August, Allison, Baqui, Abdullah H, Calvert, Anna, Chen, Janice, Cho, Iksung, Cotton, Mark F, Cutland, Clare L, Englund, Janet A, Fix, Amy, Gonik, Bernard, Hammitt, Laura, Heath, Paul T, de Jesus, Joanne N, Jones, Christine E, Khalil, Asma, Kimberlin, David W, Libster, Romina, Llapur, Conrado J, Lucero, Marilla, Pérez Marc, Gonzalo, Marshall, Helen S, Masenya, Masebole S, Martinón-Torres, Federico, Meece, Jennifer K, Nolan, Terry M, Osman, Ayman, Perrett, Kirsten P, Plested, Joyce S, Richmond, Peter C, Snape, Matthew D, Shakib, Julie H, Shinde, Vivek, Stoney, Tanya, Thomas, D. Nigel, Tita, Alan T, Varner, Michael W, Vatish, Manu, Vrbicky, Keith, Wen, Judy, Zaman, Khalequ, Zar, Heather J, Glenn, Gregory M, Fries, Louis F
Format: Journal Article
Language:English
Published: Boston Massachusetts Medical Society 30.07.2020
Subjects:
Age
Aluminum
Antibodies
F protein
Fusion protein
Gestation
Hospitalization
Hypotheses
Hypothesis testing
Hypoxemia
Infants
Infections
Nanoparticles
Objectives
Oxygen saturation
Pregnancy
Proteins
Respiratory diseases
Respiratory syncytial virus
Respiratory tract diseases
Sea level
Statistical analysis
Vaccination
Vaccine efficacy
Vaccines
Vitamin E
Womens health
ISSN:0028-4793, 1533-4406, 1533-4406
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This randomized trial of RSV F protein nanoparticle vaccination during pregnancy did not show efficacy (according to the prespecified success criterion) against RSV-associated, medically significant lower respiratory tract infection but suggested possible benefits with respect to other RSV-related outcomes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMoa1908380